期刊
MOLECULAR BIOLOGY REPORTS
卷 49, 期 12, 页码 11643-11652出版社
SPRINGER
DOI: 10.1007/s11033-022-07924-x
关键词
PMN-MDSCs; Fatty acid transporter protein 2; Receptor-interacting protein kinase 3; Immunotherapy; Bladder cancer
资金
- National Natural Science Foundation of China [81902595]
- Science and Technology Program of Guangzhou [202002030482]
This study discovered a feedback loop between FATP2 and RIPK3 pathways in PMN-MDSCs, which significantly promoted the synthesis of PGE2 and impaired the CD8(+) T cell functions. Combination therapy with inhibition of FATP2 and activation of RIPK3 effectively inhibited tumor growth.
Background Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) promote tumor immune tolerance and cause tumor immunotherapy failure. In this study, we found that high PMN-MDSCs infiltration, overexpressed fatty acid transporter protein 2 (FATP2) and underexpressed receptor-interacting protein kinase 3 (RIPK3) existed in the mouse and human bladder cancer tissues. However, the related mechanisms remain largely unknown. Methods and results Both FATP2 and RIPK3 expressions were associated with clinical stage. FATP2 knockout or up-regulating RIPK3 reduced the synthesis of prostaglandin E2 (PGE2) in PMN-MDSCs, attenuated the suppressive activity of PMN-MDSCs on CD8(+) T cells functions and inhibited the tumor growth. There was a PGE2-mediated feedback loop between FATP2 and RIPK3 pathways, which markedly promoted the immunosuppressive activity of PMN-MDSCs. Combination therapy with inhibition of FATP2 and activation of RIPK3 can effectively inhibit tumor growth. Conclusions This study demonstrated that a feedback loop between FATP2 and RIPK3 pathways in PMN-MDSCs significantly promoted the synthesis of PGE2, which severely impaired the CD8(+) T cell functions. This study may provide new ideas for immunotherapy of human bladder cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据